Immunopathogenesis of ocular toxoplasmosis and implications for treatment

Keyphrases

• Ocular Toxoplasmosis 100%
• Implications for Treatment 100%
• Immunopathogenesis 100%
• Ocular Involvement 66%
• Polymorphism 33%
• Genetic Polymorphism 33%
• Immunological Characteristics 33%
• South America 33%
• Protozoa 33%
• Clinical Management 33%
• Interferon-γ 33%
• Toxoplasma Gondii (T. gondii) 33%
• Aqueous Humor 33%
• Clinical Manifestations 33%
• Immune Response 33%
• Primary Infection 33%
• Peripheral Blood Mononuclear Cells 33%
• Virulence Factors 33%
• Parasitic Diseases 33%
• Evidence-based 33%
• Clinical Evidence 33%
• Immune Function 33%
• Parasite Proteins 33%
• Lymphocyte Subsets 33%
• Protein Kinase 33%
• Cytokinome 33%
• Parasitological 33%
• Future Therapies 33%
• Memory CD4+ T Cells 33%
• IFN Production 33%
• Expert Opinion 33%
• Drug Target 33%
• Area Cover 33%
• Chronic Infection 33%
• Cytokine Network 33%
• Antiparasitic 33%
• Immunological Mechanisms 33%
• Significant Inflammation 33%
• Appropriate Responses 33%
• Tissue Cyst 33%
• Recurrence Probability 33%
• Clinical Correlation 33%
• Ocular Trauma 33%
• Narrative Review 33%
• Parasite Virulence 33%

Immunology and Microbiology

• Toxoplasmosis 100%
• Immunopathogenesis 100%
• Infection 66%
• Genetic Polymorphism 33%
• Cytokine 33%
• Infectious Disease 33%
• Protozoa 33%
• Aqueous Humor 33%
• Toxoplasma gondii 33%
• Virulence Factor 33%
• Peripheral Blood Mononuclear Cell 33%
• Immune Response 33%
• CD4 33%
• Interferon Gamma 33%
• Parasite Protein 33%
• Lymphocyte Subpopulation 33%
• Parasitic Disease 33%
• Memory T Cell 33%
• Parasite Virulence 33%
• T Cell Subset 33%
• Drug Targeting 33%
• Inflammation 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Ocular Toxoplasmosis 100%
• Immunopathogenesis 100%
• Recurrent Disease 66%
• Inflammation 33%
• Infection 33%
• Cytokine 33%
• Toxoplasma gondii 33%
• Virulence Factor 33%
• Eye Injury 33%
• Parasitosis 33%
• Drug Delivery System 33%
• Gamma Interferon 33%
• Antiparasitic Activity 33%
• Primary Infection 33%
• Parasite Virulence 33%
• Protein Kinase 33%
• Protozoan 33%
• Parasite 33%
• Cyst 33%